ACTU Actuate Therapeutics Inc
Healthcare$2.20-7.56%ClosedMarket Cap: $52.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
14.80
P/S
0.00
EV/EBITDA
-2.26
DCF Value
$0.54
FCF Yield
-34.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-430.9%
ROA
-241.7%
ROIC
-521.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-5.7M | $-5.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.7M | $-4.6M | $— | — |
| FY null | $0.00 | NaN% | $-22.5M | $-22.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.5M | $-5.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.0M | $-5.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.4M | $-6.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-6.6M | $-6.4M | $— | — |
| FY null | $0.00 | NaN% | $-25.2M | $-27.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.4M | $-6.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.4M | $-6.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-7.8M | $-8.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-7.6M | $-7.6M | $-0.50 | — |